KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLand & ImprovementsLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Unitedhealth (UNH) Cash & Equivalents (2016 - 2025)

Unitedhealth (UNH) has disclosed Cash & Equivalents for 15 consecutive years, with $776.0 million as the latest value for Q4 2023.

  • On a quarterly basis, Cash & Equivalents rose 191.73% to $776.0 million in Q4 2023 year-over-year; TTM through Dec 2023 was $776.0 million, a 191.73% increase, with the full-year FY2023 number at $776.0 million, up 191.73% from a year prior.
  • Cash & Equivalents was $776.0 million for Q4 2023 at Unitedhealth, up from $266.0 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $25.5 billion in Q1 2022 to a low of $46.0 million in Q4 2019.
  • A 5-year average of $11.4 billion and a median of $12.4 billion in 2019 define the central range for Cash & Equivalents.
  • Peak YoY movement for Cash & Equivalents: tumbled 99.58% in 2019, then soared 739.92% in 2021.
  • Unitedhealth's Cash & Equivalents stood at $46.0 million in 2019, then soared by 460.87% to $258.0 million in 2020, then skyrocketed by 739.92% to $2.2 billion in 2021, then tumbled by 87.72% to $266.0 million in 2022, then skyrocketed by 191.73% to $776.0 million in 2023.
  • Per Business Quant, the three most recent readings for UNH's Cash & Equivalents are $776.0 million (Q4 2023), $266.0 million (Q4 2022), and $25.5 billion (Q1 2022).